Patents by Inventor Xiaolei ZE

Xiaolei ZE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 207-27 and use thereof
    Patent number: 11812770
    Abstract: The present application relates to a Lactobacillus paracasei or progeny thereof. Specifically, the present application relates to Lactobacillus paracasei 207-27 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Lactobacillus paracasei 207-27 and the composition, culture, food product or dietary supplement containing the same in medicine.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: November 14, 2023
    Assignee: BYHEALTH CO., LTD.
    Inventors: Xuguang Zhang, Xiaolei Ze, Ruikun He, Fang He
  • 207-1 and use thereof
    Patent number: 11767503
    Abstract: The present application relates to a Bifidobacterium breve or progeny thereof. Specifically, the present application relates to Bifidobacterium breve 207-1 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Bifidobacterium breve 207-1 and the composition, culture, food product or dietary supplement containing the same in medicine.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: September 26, 2023
    Assignee: BYHEALTH CO., LTD.
    Inventors: Xiaolei Ze, Xuguang Zhang, Ruikun He, Fang He
  • LACTOBACILLUS PARACASEI 207-27 AND USE THEREOF
    Publication number: 20230085303
    Abstract: The present application relates to a Lactobacillus paracasei or progeny thereof. Specifically, the present application relates to Lactobacillus paracasei 207-27 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Lactobacillus paracasei 207-27 and the composition, culture, food product or dietary supplement containing the same in medicine.
    Type: Application
    Filed: February 1, 2021
    Publication date: March 16, 2023
    Inventors: Xuguang ZHANG, Xiaolei ZE, Ruikun HE, Fang HE
  • BIFIDOBACTERIUM BREVE 207-1 AND USE THEREOF
    Publication number: 20220333062
    Abstract: The present application relates to a Bifidobacterium breve or progeny thereof. Specifically, the present application relates to Bifidobacterium breve 207-1 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Bifidobacterium breve 207-1 and the composition, culture, food product or dietary supplement containing the same in medicine.
    Type: Application
    Filed: February 2, 2021
    Publication date: October 20, 2022
    Inventors: Xiaolei ZE, Xuguang ZHANG, Ruikun HE, Fang HE
  • COMBINATIONS OF OSTEOPONTIN AND 2'-FUCOSYLLACTOSE FOR USE AS MEDICAMENTS
    Publication number: 20210236605
    Abstract: A combination of osteopontin (OPN) and 2?-fucosyllactose (2-FL) is used in the prevention or the treatment of immunological diseases or disorders due to inflammatory factors secretion affecting a human or an animal subject. The said combination is useful, in particular, in the prevention or the treatment of diseases or disorders due cytokine secretion, e.g. INF-?, IL-2, IL-4, IL-17, IL-6, IL-10, TGF-?, Tbet, GA-TA3 and NFkB and/or immunoglobulin secretion, e.g. IgE and Ig1.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 5, 2021
    Inventors: Béatrice DUTHEY, Jonathan LANE, Patrice MALARD, Xiaolei ZE